• Understand the impact of changing regulations on interactions between healthcare professionals and pharma
• The future of your external stakeholder engagements: speak a common language to establish shared objectives and goals for optimal benefit
• Learn how to deal with increasing cross-boundary relationships whilst maintaining compliance
• Important factors to consider when determining payments to your KOLs with changing regulations differing between countries

• Fully understand the implications that your company faces under the UK's Bribery Act 2010
• Ways to deal with the changing dynamic of relationships under new regulations and implement adequate procedures within your company
• Understand the impact of new regulations on your KOLs and the most effective ways to ensure compliance

• Hear directly from the regulators about how you can work with them to achieve better outcomes
• Key examples of mutually beneficial collaborations with pharma
• Ask the experts your questions about where the boundaries lie with your KOL and MSL interactions

• How to adapt your strategy in the changing environment: regulation and drug patent insight
• Stakeholder expectations: understand expectations and what they are willing to implement
• Establish cross-functional goals to create internal unity: how to engage the top KOLs and beat off external competition

• Understand how physicians want to use social media to communicate with pharma
• Learn how e-patients lead the way to better healthcare
• Practical methods to improve online communication with your stakeholders

• The best ways to implement KOL feedback into your company strategy and the importance of involving upper management
• Understand the differences between KOL programme management and individual MSL success
• How to build effective long-term relationships based on measurement of success from a MSL engagement
• The benefits of implementing new technology to evaluate success of engagement: feedback from successful ROE measurement initiatives

• The KOL's perspective: examples of what works and what doesn't
• Understand your KOLs interests and needs to ensure you can support them in a mutually beneficial way
• Create long-lasting interactions by learning how to build value and develop KOL relationships further

• Learn how to utilise the in-depth knowledge of an MSL: focus on the role of an MSL as a scientific peer
• How to place MSLs within your company to aid the transition of changing relationships with payers under new regulations
• Ways to bridge the gap between patient reported outcomes and the payers backing the drug

Gain an understanding of:

• Stakeholder Relations environmental changes and challenges
• KOL strategies across the lifecycle
• A stepwise approach to Stakeholder Relations Business Planning

Leave with knowledge and tools that are actionable for individual company knowledge and application

• Create a consistent and unified system of communication within your organisation to result in a better relationship with KOLs/MSLs
• KAM principles to help integrate and streamline KOL interactions
• Hear key examples of successful cross-communication systems

• Understand who your new KOLs are and what they can add to your business
• Clinical treatment guidelines: understand the landscape and cooperate with decision makers
• Refresh your pool of KOLs: build and support relationships with a new generation of KOLs to stay ahead of the competition
• New approaches: how do adapt your engagement plan to build a different type of relationship with future stakeholders

• An MSL's perspective of how to select and engage your KOLs: find the appropriate leader based on the life cycle of your product
• How to identify the right KOL for you and achieve a winning result with your product: advantages and limitations of using software to do this
• Engage with the "rising stars" to create strong relationships for the future

• Hear the best ways to work with KOLs to develop new technologies and new approaches
• Extract the right information from your KOL in order to successfully implement this back into your company strategy
• Discover the best way to manage intellectual property to get the best out of new products on the market

1. Where does Pharma stand in leveraging influence networks? (Hervé Drevot, VP, Cross Worlds HealthCare Professionals)
2. Transparency: where exactly do the boundaries lie? (Julian Jenkins, Head of Medical Affairs, Ferring Pharmaceuticals)
3. Effective metrics for assessing the success and value of KOL interactions (Raymund Zinck, Director Medical Affairs, Baxter)
4. Emerging KOLS: the best ways to manage relationships with patient groups and payers (Simon Freedman, VP, Torax Medical)
5. Using digital channels efficiently to build a better KOL business strategy (Emma D'Arcy, Senior Consultant, Complete Digital)

• Hear KOLs perspective on the use of digital channels and what reservations they have surrounding this
• Engage in professional networks to communicate with your KOLs
• Improve your engagement strategy by learning what apps KOLs use and ones they don't

• How you can meet the needs of your key payers as they gain more influence in the reimbursement process
• The best ways to work with external policy makers to overcome the obstacles in the reimbursement process
• Leverage the knowledge of your field teams to maximise payer buy-in

• Learn how to understand the needs of patient groups and discover the best ways to support and engage these key influencers
• Find out how to align to patient group goals to achieve better patient outcomes
• The importance of guideline compliance to maintain integrity and transparency in order to build a highly effective partnership

• Defining the Stakeholder scope
• Evolving importance of non clinical stakeholders
• Why it's important to get it right